Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective.
Evidence-Based Cognitive Rehabilitation for Persons with Multiple Sclerosis: An Updated Systematic Review 2016 to 2024.
Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.
T cell-mediated immunodysregulation in multiple sclerosis: from pathogenic subsets to therapeutic advances.
BASHY dyes as modular chromophores for multifaceted biorelevant applications: from imaging to photodynamic therapy.
Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical Trial.
Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China.
Unveiling Remyelinating Properties of Roflumilast in CPZ-Induced Neuronal Demyelination in Mice.
Early Myelination Supports the Establishment of Consistent Handedness.
No association of complex regional pain syndrome and other neurological disorders with human papillomavirus vaccination in a large-scale real-world database.
News in autoimmune myelitis in the oncological context.
Focal white matter lesions drive grey matter inflammation and synapse loss.
A multilevel linguistic analysis reveals linguistic impairments in persons with multiple sclerosis.
Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.
Treg-derived IFN-γ supports the differentiation of Th1-Treg in tumor immunity and autoimmunity.
Multi-tier signaling and chromatin remodeling coordinate microglia inflammatory states and activities associated with demyelination.
The GPR17 agonist galinex restores oligodendrocyte maturation under inflammatory conditions.
CRISPR-Based Gene Therapy for Brain Disease.
Relapse-associated worsening in apolipoprotein E ε4 carriers with relapsing multiple sclerosis.
The hypoxia-inflammation cycle as a key mechanism of smoldering inflammation and progression in multiple sclerosis.
Compromised blood-brain barrier in traumatic brain injury model of : A unique window to demonstrate restoration of behavioral, cellular, and neurochemical deficits by limonin.
Radiologists' recommendations following MRI for optic neuritis: influence of report wording and patient accessibility in a tertiary neuro-ophthalmology clinic.
Cognitively stimulating activities in multiple sclerosis: Results of a randomized controlled trial.
A more optimistic outlook about disease-modifying therapies and depressive symptoms in multiple sclerosis: A cross-sectional analysis.
A multidisciplinary Delphi consensus on the formulation of an optimized oral diet for dysphagia and malnutrition (FOOD-DM).

Pages